메뉴 건너뛰기




Volumn 27, Issue 21, 2009, Pages 3445-3451

Adjuvant hormonal therapy use among insured, low-income women with breast cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; EXEMESTANE; LETROZOLE; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; PHARMACEUTICAL VEHICLES AND ADDITIVES;

EID: 70249110823     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.2419     Document Type: Article
Times cited : (165)

References (58)
  • 1
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
    • Early Breast Cancer Trialists' Collaborative Group EBCTCG
    • Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
    • (2005) Lancet , vol.365 , pp. 1687-1717
  • 2
    • 11444251764 scopus 로고    scopus 로고
    • Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
    • Howell A, Cuzick J, Baum M, et al: Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365:60-62, 2005
    • (2005) Lancet , vol.365 , pp. 60-62
    • Howell, A.1    Cuzick, J.2    Baum, M.3
  • 3
    • 10744223655 scopus 로고    scopus 로고
    • A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
    • Coombes RC, Hall E, Gibson LJ, et al: A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081-1092, 2004
    • (2004) N Engl J Med , vol.350 , pp. 1081-1092
    • Coombes, R.C.1    Hall, E.2    Gibson, L.J.3
  • 4
    • 24644519961 scopus 로고    scopus 로고
    • Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole Trial
    • Boccardo F, Rubagotti A, Puntoni M, et al: Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole Trial. J Clin Oncol 23:5138-5147, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 5138-5147
    • Boccardo, F.1    Rubagotti, A.2    Puntoni, M.3
  • 5
    • 23444446523 scopus 로고    scopus 로고
    • Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: Combined results of ABCSG trial 8 and ARNO 95 trial
    • Jakesz R, Jonat W, Gnant M, et al: Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: Combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366:455-462, 2005
    • (2005) Lancet , vol.366 , pp. 455-462
    • Jakesz, R.1    Jonat, W.2    Gnant, M.3
  • 6
    • 29544433211 scopus 로고    scopus 로고
    • A comparison of letrozole and tamoxifen in post-menopausal women with early breast cancer
    • Thürlimann B, Keshaviah A, Coates AS, et al: A comparison of letrozole and tamoxifen in post-menopausal women with early breast cancer. N Engl J Med 353:2747-2757, 2005
    • (2005) N Engl J Med , vol.353 , pp. 2747-2757
    • Thürlimann, B.1    Keshaviah, A.2    Coates, A.S.3
  • 7
    • 24744450378 scopus 로고    scopus 로고
    • Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA 17
    • Goss PE, Ingle JN, Martino S, et al: Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA 17. J Natl Cancer Inst 97:1262-1271, 2005
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1262-1271
    • Goss, P.E.1    Ingle, J.N.2    Martino, S.3
  • 8
    • 20044382779 scopus 로고    scopus 로고
    • American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status
    • Winer EP, Hudis C, Burstein HJ, et al: American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004. J Clin Oncol 23:619-629, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 619-629
    • Winer, E.P.1    Hudis, C.2    Burstein, H.J.3
  • 9
    • 25844449130 scopus 로고    scopus 로고
    • Adherence beliefs among breast cancer patients taking tamoxifen
    • Grunfeld EA, Hunter MS, Sikka P, et al: Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns 59:97-102, 2005
    • (2005) Patient Educ Couns , vol.59 , pp. 97-102
    • Grunfeld, E.A.1    Hunter, M.S.2    Sikka, P.3
  • 10
    • 4344667475 scopus 로고    scopus 로고
    • Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer
    • Fink AK, Gurwitz J, Rakowski W, et al: Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. J Clin Oncol 22:3309-3315, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 3309-3315
    • Fink, A.K.1    Gurwitz, J.2    Rakowski, W.3
  • 11
    • 0036847257 scopus 로고    scopus 로고
    • Tamoxifen non-compliance: Does it matter?
    • Murthy V, Bharia G, Sarin R: Tamoxifen non-compliance: Does it matter? Lancet Oncol 3:654, 2002
    • (2002) Lancet Oncol , vol.3 , pp. 654
    • Murthy, V.1    Bharia, G.2    Sarin, R.3
  • 12
    • 0035863386 scopus 로고    scopus 로고
    • Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women
    • Demissie S, Silliman RA, Lash TL: Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women. J Clin Oncol 19:322-328, 2001
    • (2001) J Clin Oncol , vol.19 , pp. 322-328
    • Demissie, S.1    Silliman, R.A.2    Lash, T.L.3
  • 13
    • 0027229141 scopus 로고
    • Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring
    • Waterhouse DM, Calzone KA, Mele C, et al: Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 11:1189-1197, 1993
    • (1993) J Clin Oncol , vol.11 , pp. 1189-1197
    • Waterhouse, D.M.1    Calzone, K.A.2    Mele, C.3
  • 14
  • 15
    • 39149107837 scopus 로고    scopus 로고
    • Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer
    • Owusu C, Buist DS, Field TS, et al: Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol 26:549-555, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 549-555
    • Owusu, C.1    Buist, D.S.2    Field, T.S.3
  • 16
    • 0037441639 scopus 로고    scopus 로고
    • Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
    • Partridge AH, Wang PS, Winer EP, et al: Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21:602-606, 2003
    • (2003) J Clin Oncol , vol.21 , pp. 602-606
    • Partridge, A.H.1    Wang, P.S.2    Winer, E.P.3
  • 17
    • 39149111976 scopus 로고    scopus 로고
    • Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
    • Partridge AH, Lafountain A, Mayer E, et al: Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26:556-562, 2008
    • (2008) J Clin Oncol , vol.26 , pp. 556-562
    • Partridge, A.H.1    Lafountain, A.2    Mayer, E.3
  • 18
    • 79953092632 scopus 로고    scopus 로고
    • Association of poor adherence to prescribed tamoxifen with risk of death from breast cancer
    • San Francisco, CA, September 7-8, abstr 130
    • Thompson AM, Dewar J, Fahey T, et al: Association of poor adherence to prescribed tamoxifen with risk of death from breast cancer. 2007 Breast Cancer Symposium, San Francisco, CA, September 7-8, 2007 (abstr 130)
    • (2007) 2007 Breast Cancer Symposium
    • Thompson, A.M.1    Dewar, J.2    Fahey, T.3
  • 19
    • 0027183973 scopus 로고
    • The relation between health insurance coverage and clinical outcomes among women with breast cancer
    • Ayanian JZ, Kohler BA, Abe T, et al: The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 329:326-331, 1993
    • (1993) N Engl J Med , vol.329 , pp. 326-331
    • Ayanian, J.Z.1    Kohler, B.A.2    Abe, T.3
  • 20
    • 0020064967 scopus 로고
    • Race and socioeconomic status in survival from breast cancer
    • Dayal HH, Power RN, Chiu C: Race and socioeconomic status in survival from breast cancer. J Chronic Dis 35:675-683, 1982
    • (1982) J Chronic Dis , vol.35 , pp. 675-683
    • Dayal, H.H.1    Power, R.N.2    Chiu, C.3
  • 21
    • 0030999351 scopus 로고    scopus 로고
    • Recent trends in breast cancer mortality among white and black US women
    • Chevarley F, White E: Recent trends in breast cancer mortality among white and black US women. Am J Public Health 87:775-781, 1997
    • (1997) Am J Public Health , vol.87 , pp. 775-781
    • Chevarley, F.1    White, E.2
  • 22
    • 0032750175 scopus 로고    scopus 로고
    • Survival differences in breast cancer among racial/ ethnic groups: A population-based study
    • Boyer-Chammard A, Taylor TH, Anton-Culver H: Survival differences in breast cancer among racial/ ethnic groups: A population-based study. Cancer Detect Prev 23:463-473, 1999
    • (1999) Cancer Detect Prev , vol.23 , pp. 463-473
    • Boyer-Chammard, A.1    Taylor, T.H.2    Anton-Culver, H.3
  • 23
    • 0142248897 scopus 로고    scopus 로고
    • Does stage at diagnosis influence the observed relationship between socioeconomic status and breast cancer incidence, case-fatality, and mortality?
    • Yabroff KR, Gordis L: Does stage at diagnosis influence the observed relationship between socioeconomic status and breast cancer incidence, case-fatality, and mortality? Soc Sci Med 57:2265-2279, 2003
    • (2003) Soc Sci Med , vol.57 , pp. 2265-2279
    • Yabroff, K.R.1    Gordis, L.2
  • 24
    • 0027424291 scopus 로고
    • Race, income, and survival from breast cancer at two public hospitals
    • Ansell D, Whitman S, Lipton R, et al: Race, income, and survival from breast cancer at two public hospitals. Cancer 72:2974-2978, 1993
    • (1993) Cancer , vol.72 , pp. 2974-2978
    • Ansell, D.1    Whitman, S.2    Lipton, R.3
  • 25
    • 0023013743 scopus 로고
    • Social class and black-white differences in breast cancer survival
    • Bassett MT, Krieger N: Social class and black-white differences in breast cancer survival. Am J Public Health 76:1400-1403, 1986
    • (1986) Am J Public Health , vol.76 , pp. 1400-1403
    • Bassett, M.T.1    Krieger, N.2
  • 26
    • 84942479462 scopus 로고
    • Treatment differences and other prognostic factors related to breast cancer survival: Delivery systems and medical outcomes
    • Lee-Feldstein A, Anton-Culver H, Feldstein PJ: Treatment differences and other prognostic factors related to breast cancer survival: Delivery systems and medical outcomes. JAMA 271:1163-1168, 1994
    • (1994) JAMA , vol.271 , pp. 1163-1168
    • Lee-Feldstein, A.1    Anton-Culver, H.2    Feldstein, P.J.3
  • 27
    • 0034667985 scopus 로고    scopus 로고
    • The effect of less than definitive care on breast carcinoma recurrence and mortality
    • Lash TL, Silliman RA, Guadagnoli E, et al: The effect of less than definitive care on breast carcinoma recurrence and mortality. Cancer 89:1739-1747, 2000
    • (2000) Cancer , vol.89 , pp. 1739-1747
    • Lash, T.L.1    Silliman, R.A.2    Guadagnoli, E.3
  • 28
    • 37249061682 scopus 로고    scopus 로고
    • Mortality impact of less-than-standard therapy in older breast cancer patients
    • Yood MU, Owusu C, Buist DS, et al: Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg 206:66-75, 2008
    • (2008) J Am Coll Surg , vol.206 , pp. 66-75
    • Yood, M.U.1    Owusu, C.2    Buist, D.S.3
  • 29
    • 75749093171 scopus 로고    scopus 로고
    • Wikipedia contributors: Medicaid. Wikipedia, The Free Encyclopedia. http://en.wikipedia.org/wiki/ Medicaid
    • Wikipedia contributors: Medicaid. Wikipedia, The Free Encyclopedia. http://en.wikipedia.org/wiki/ Medicaid
  • 30
    • 75749130483 scopus 로고    scopus 로고
    • Patterns of care among breast cancer patients with financial need: Information from a Medicaid-claims and tumor registry linked database
    • suppl; abstr 6037, 537s
    • Kimmick GG, Camacho F, Balkrishnan R, et al: Patterns of care among breast cancer patients with financial need: Information from a Medicaid-claims and tumor registry linked database. J Clin Oncol 23:537s, 2005 (suppl; abstr 6037)
    • (2005) J Clin Oncol , vol.23
    • Kimmick, G.G.1    Camacho, F.2    Balkrishnan, R.3
  • 31
    • 53649101821 scopus 로고    scopus 로고
    • Racial differences in patterns of care among medicaidenrolled breast cancer patients
    • Kimmick G, Camacho F, Foley KL, et al: Racial differences in patterns of care among medicaidenrolled breast cancer patients. J Oncol Pract 2:205-213, 2006
    • (2006) J Oncol Pract , vol.2 , pp. 205-213
    • Kimmick, G.1    Camacho, F.2    Foley, K.L.3
  • 32
    • 33846328685 scopus 로고    scopus 로고
    • Survival disadvantage among Medicaid-insured breast cancer patients treated with breast conserving surgery without radiation therapy
    • Foley KL, Kimmick G, Camacho F, et al: Survival disadvantage among Medicaid-insured breast cancer patients treated with breast conserving surgery without radiation therapy. Breast Cancer Res Treat 101:207-214, 2007
    • (2007) Breast Cancer Res Treat , vol.101 , pp. 207-214
    • Foley, K.L.1    Kimmick, G.2    Camacho, F.3
  • 33
    • 75749137109 scopus 로고    scopus 로고
    • Use of cancer registry data for research on patterns of breast cancer care of individuals with Medicaid insurance
    • suppl; abstr 6021, 533s
    • Anderson RT, Camacho FT, Balkrishnan R, et al: Use of cancer registry data for research on patterns of breast cancer care of individuals with Medicaid insurance. J Clin Oncol 24:533s, 2005 (suppl; abstr 6021)
    • (2005) J Clin Oncol , vol.24
    • Anderson, R.T.1    Camacho, F.T.2    Balkrishnan, R.3
  • 34
  • 35
    • 0024060815 scopus 로고
    • A general method of compliance assessment using centralized pharmacy records: Description and validation
    • Steiner JF, Koepsell TD, Fihn SD, et al: A general method of compliance assessment using centralized pharmacy records: Description and validation. Med Care 26:814-823, 1988
    • (1988) Med Care , vol.26 , pp. 814-823
    • Steiner, J.F.1    Koepsell, T.D.2    Fihn, S.D.3
  • 36
    • 0031046049 scopus 로고    scopus 로고
    • The assessment of refill compliance using pharmacy records: Methods, validity, and applications
    • Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: Methods, validity, and applications. J Clin Epidemiol 50:105-116, 1997
    • (1997) J Clin Epidemiol , vol.50 , pp. 105-116
    • Steiner, J.F.1    Prochazka, A.V.2
  • 37
    • 22544468809 scopus 로고    scopus 로고
    • Estimating medication persistency using administrative claims data
    • Sikka R, Xia F, Aubert RE: Estimating medication persistency using administrative claims data. Am J Manag Care 11:449-457, 2005
    • (2005) Am J Manag Care , vol.11 , pp. 449-457
    • Sikka, R.1    Xia, F.2    Aubert, R.E.3
  • 38
    • 33748343357 scopus 로고    scopus 로고
    • Methods for evaluation of medication adherence and persistence using automated databases
    • discussion 575-577
    • Andrade SE, Kahler KH, Frech F, et al: Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15:565-574, 2006; discussion 575-577
    • Pharmacoepidemiol Drug Saf , vol.15 , Issue.565-574 , pp. 2006
    • Andrade, S.E.1    Kahler, K.H.2    Frech, F.3
  • 39
    • 0036272422 scopus 로고    scopus 로고
    • Patient compliance and persistence with anti-hyperglycemic therapy: Evaluation of a population of type 2 diabetic patients
    • Dailey G, Kim MS, Lian JF: Patient compliance and persistence with anti-hyperglycemic therapy: Evaluation of a population of type 2 diabetic patients. J Int Med Res 30:71-79, 2002
    • (2002) J Int Med Res , vol.30 , pp. 71-79
    • Dailey, G.1    Kim, M.S.2    Lian, J.F.3
  • 40
    • 0036677782 scopus 로고    scopus 로고
    • Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data
    • Dasgupta S, Oates V, Bookhart BK, et al: Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data. Am J Manag Care 8:S255-S261, 2002
    • (2002) Am J Manag Care , vol.8
    • Dasgupta, S.1    Oates, V.2    Bookhart, B.K.3
  • 41
  • 42
    • 44649195991 scopus 로고    scopus 로고
    • Johnson CH, Adamo M eds, Bethesda, MD, National Cancer Institute, NIH Publication 07-5581
    • Johnson CH, Adamo M (eds): SEER Program Coding and Staging Manual 2007. Bethesda, MD, National Cancer Institute, NIH Publication 07-5581, 2007
    • (2007) SEER Program Coding and Staging Manual 2007
  • 43
    • 0030472186 scopus 로고    scopus 로고
    • Practical considerations on the use of the Charlson Comorbidity Index with administrative data bases
    • D'Hoore W, Bouckaert A, Telquin C: Practical considerations on the use of the Charlson Comorbidity Index with administrative data bases. J Clin Epidemiol 49:1429-1433, 1996
    • (1996) J Clin Epidemiol , vol.49 , pp. 1429-1433
    • D'Hoore, W.1    Bouckaert, A.2    Telquin, C.3
  • 44
    • 0037114664 scopus 로고    scopus 로고
    • Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients
    • Blackman SB, Lash TL, Fink AK, et al: Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients. Cancer 95: 2465-2472, 2002
    • (2002) Cancer , vol.95 , pp. 2465-2472
    • Blackman, S.B.1    Lash, T.L.2    Fink, A.K.3
  • 45
    • 4644293320 scopus 로고    scopus 로고
    • Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997
    • Du XL, Key CR, Osborne C: Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997. Breast J 10:433-439, 2004
    • (2004) Breast J , vol.10 , pp. 433-439
    • Du, X.L.1    Key, C.R.2    Osborne, C.3
  • 46
    • 4344707888 scopus 로고    scopus 로고
    • Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer
    • Fyles AW, McCready DR, Manchul LA, et al: Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351:963-970, 2004
    • (2004) N Engl J Med , vol.351 , pp. 963-970
    • Fyles, A.W.1    McCready, D.R.2    Manchul, L.A.3
  • 47
    • 10344238569 scopus 로고    scopus 로고
    • Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor- positive tumors
    • Fisher B, Dignam J, Bryant J, et al: Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor- positive tumors. J Natl Cancer Inst 88:1529-1542, 1996
    • (1996) J Natl Cancer Inst , vol.88 , pp. 1529-1542
    • Fisher, B.1    Dignam, J.2    Bryant, J.3
  • 48
    • 0033549344 scopus 로고    scopus 로고
    • Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
    • Fisher B, Dignam J, Wolmark N, et al: Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353:1993-2000, 1999
    • (1999) Lancet , vol.353 , pp. 1993-2000
    • Fisher, B.1    Dignam, J.2    Wolmark, N.3
  • 49
    • 0035865147 scopus 로고    scopus 로고
    • Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-23
    • Fisher B, Anderson S, Tan-Chiu E, et al: Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-23. J Clin Oncol 19:931-942, 2001
    • (2001) J Clin Oncol , vol.19 , pp. 931-942
    • Fisher, B.1    Anderson, S.2    Tan-Chiu, E.3
  • 50
    • 0037108675 scopus 로고    scopus 로고
    • Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less
    • Fisher B, Bryant J, Dignam JJ, et al: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20:4141-4149, 2002
    • (2002) J Clin Oncol , vol.20 , pp. 4141-4149
    • Fisher, B.1    Bryant, J.2    Dignam, J.J.3
  • 51
    • 0742272455 scopus 로고    scopus 로고
    • How well do patients report noncompliance with anti-hypertensive medications? A comparison of self-report versus filled prescriptions
    • Wang PS, Benner JS, Glynn RJ, et al: How well do patients report noncompliance with anti-hypertensive medications? A comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf 13:11-19, 2004
    • (2004) Pharmacoepidemiol Drug Saf , vol.13 , pp. 11-19
    • Wang, P.S.1    Benner, J.S.2    Glynn, R.J.3
  • 52
    • 33847373003 scopus 로고    scopus 로고
    • Early discontinuation of tamoxifen: A lesson for oncologists
    • Barron TI, Connolly R, Bennett K, et al: Early discontinuation of tamoxifen: A lesson for oncologists. Cancer 109:832-839, 2007
    • (2007) Cancer , vol.109 , pp. 832-839
    • Barron, T.I.1    Connolly, R.2    Bennett, K.3
  • 53
    • 1642365729 scopus 로고    scopus 로고
    • Social support and patient adherence to medical treatment: A meta-analysis
    • DiMatteo MR: Social support and patient adherence to medical treatment: A meta-analysis. Health Psychol 23:207-218, 2004
    • (2004) Health Psychol , vol.23 , pp. 207-218
    • DiMatteo, M.R.1
  • 54
    • 29144461772 scopus 로고    scopus 로고
    • Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews
    • Du XL, Key CR, Dickie L, et al: Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews. J Clin Epidemiol 59:53-60, 2006
    • (2006) J Clin Epidemiol , vol.59 , pp. 53-60
    • Du, X.L.1    Key, C.R.2    Dickie, L.3
  • 55
    • 33644831234 scopus 로고    scopus 로고
    • Insurance status and the use of guideline therapy in the treatment of selected cancers
    • Harlan LC, Greene AL, Clegg LX, et al: Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol 23: 9079-9088, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 9079-9088
    • Harlan, L.C.1    Greene, A.L.2    Clegg, L.X.3
  • 56
    • 33645729721 scopus 로고    scopus 로고
    • NCCN Task Force Report: Adjuvant Therapy for Breast Cancer
    • suppl 1
    • Carlson RW, Brown E, Burstein HJ, et al: NCCN Task Force Report: Adjuvant Therapy for Breast Cancer. J Natl Compr Canc Netw 4:S1-S26, 2006 (suppl 1)
    • (2006) J Natl Compr Canc Netw , vol.4
    • Carlson, R.W.1    Brown, E.2    Burstein, H.J.3
  • 57
    • 0034329443 scopus 로고    scopus 로고
    • Adjuvant Therapy for Breast Cancer
    • Adjuvant Therapy for Breast Cancer. NIH Consens Statement 17:1, 2000
    • (2000) NIH Consens Statement , vol.17 , pp. 1
  • 58
    • 34547852275 scopus 로고    scopus 로고
    • Progress and promise: Highlights of the international expert consensus on the primary therapy of early breast cancer 2007
    • Goldhirsch A, Wood WC, Gelber RD, et al: Progress and promise: Highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18:1133-1144, 2007
    • (2007) Ann Oncol , vol.18 , pp. 1133-1144
    • Goldhirsch, A.1    Wood, W.C.2    Gelber, R.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.